Key Highlights
- UnitedHealth delivered Q1 adjusted EPS of $7.23, surpassing analyst expectations of $6.58, while revenue reached $111.7 billion compared to the anticipated $109.4 billion.
- Shares climbed 5.7% to reach $342 during premarket hours on Tuesday.
- Annual adjusted EPS forecast increased to above $18.25, representing an uptick from the January projection of $17.75.
- The medical care ratio enhanced to 83.9% during Q1 2026, showing improvement from 84.8% in the same period last year.
- The healthcare giant is committing a minimum of $1.5 billion toward artificial intelligence initiatives to counter a $6 billion Medicare reimbursement challenge.
UnitedHealth Group delivered robust first-quarter performance, exceeding Wall Street projections for both profit and revenue while enhancing its annual forecast. These results emerge as the healthcare giant advances its transformation initiatives under CEO Stephen Hemsley, who resumed leadership last May.
Adjusted earnings for the first quarter reached $7.23 per share, significantly surpassing the consensus analyst forecast of $6.58. Total revenue climbed to $111.7 billion, exceeding expectations of $109.4 billion. The company reported net income of $6.28 billion, translating to $6.90 per share.
Shares surged 5.7% to $342 during premarket trading on Tuesday.
UnitedHealth Group Incorporated, UNH
The company elevated its full-year adjusted EPS projection to exceed $18.25, marking an increase from the $17.75 forecast issued in January. CFO Wayne DeVeydt informed Barron’s that management would prefer to observe second-quarter results before contemplating additional guidance adjustments. “We’d like to just see a few more months get under our belt,” he explained.
UnitedHealthcare division revenues expanded to $86.3 billion during the quarter, advancing from $84.6 billion in Q1 2025. The operating margin strengthened to 6.6%, climbing from 6.2% year-over-year.
Healthcare Expenses Demonstrate Progress
Among the most encouraging indicators in the quarterly report was the medical care ratio — representing the portion of premium income allocated to healthcare expenses. This metric declined to 83.9% in Q1 2026 from 84.8% during Q1 2025. This represents a substantial improvement following the ratio’s spike to 91.5% in Q4 2025.
Management credited the enhancement to disciplined cost controls and beneficial reserve adjustments. However, heightened utilization patterns and increased unit costs continued to present some offsetting pressures.
UnitedHealth has been strategically withdrawing from loss-generating markets, including select individual ACA marketplace plans and particular Medicare Advantage service areas. This strategic repositioning resulted in membership contraction — declining from 49.8 million at 2025 year-end to 49.1 million in Q1 2026. Medicare Advantage membership decreased by 965,000 members during the period.
Optum Performance and Artificial Intelligence Commitment
Optum Health, which faced operational headwinds throughout much of 2025, generated $1.3 billion in adjusted operating earnings during Q1. DeVeydt characterized it as a “very good start” relative to the full-year target exceeding $1.6 billion. “We view this as a multiyear journey,” he noted.
UnitedHealth is deploying a minimum of $1.5 billion into artificial intelligence technologies this year. Management indicates these technology investments are instrumental in addressing a $6 billion pressure from previous Medicare reimbursement modifications. DeVeydt emphasized that the return on investment timeline for AI projects is “very short.”
Earlier this month, Medicare officials announced an average 2.48% payment rate increase for health insurers next year. UNH shares had already gained 9% following that announcement. DeVeydt recognized the increase “didn’t fully address” prevailing medical cost trends, indicating that benefit reductions will remain necessary in 2026.
Morgan Stanley elevated UNH to “top pick” status on April 16, pointing to expectations for a “string of clean quarters” following the more constructive Medicare rate decision.
UnitedHealthcare’s employer-sponsored self-funded business helped mitigate some membership declines, while the company’s OptumRx pharmacy benefit management division also bolstered overall revenue expansion.
